Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Life360, Inc. Director's Dealing 2021

Sep 14, 2021

30724_rns_2021-09-14_6fc683bd-3d62-4cde-95d8-5f831aa3ddeb.pdf

Director's Dealing

Open in viewer

Opens in your device viewer

Appendix 3Y Change of Director’s Interest Notice

Rule 3.19A.2

Appendix 3Y

Change of Director’s Interest Notice

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.

Introduced 30/09/01 Amended 01/01/11

Name of entity Life360, inc.
ARBN 629 412 942

We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.

We (the entity) give ASX the following
the director for the purposes of section
information under listing rule 3.19A.2 and as agent for
205G of the Corporations Act.
Name of Director Randi Zuckerberg
Date of last notice 15 June 2021

Part 1 - Change of director’s relevant interests in securities

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part.

Direct or indirect interest Direct
Nature of indirect interest
(including registered holder)
Note: Provide details of the circumstances giving rise to the relevant
interest.
Date of change 8 September 2021 (PDT)
No. of securities held prior to change
601 Shares (equivalent to 1,803 CHESS
Depositary Interests (CDIs))

16,101 Options over Shares of Common
Stock (Options)

1,881 Restricted Stock Units (RSUs)
Class Shares of Common Stock (Shares) &
RSUs
Number acquired 470 Shares
  • See chapter 19 for defined terms.

01/01/2011 Appendix 3Y Page 1

Appendix 3Y Change of Director’s Interest Notice

Number disposed 470 RSUs (having vested)
Value/Consideration
Note: If consideration is non‐cash, provide details and estimated
valuation
Shares are issued following the vesting
and settlement of 470 RSUs which were
granted in lieu of the payment of Director
and Committee Fees1
No. of securities held after change
1,071 Shares (equivalent to 3,213
CHESS Depositary Interests (CDIs))

16,101 Options

1,411 RSUs
Nature of change
Example: on‐market trade, off‐market trade, exercise of options,
issue of securities under dividend reinvestment plan, participation in
buy‐back
Issue of Shares following the vesting and
settlement of RSUs.

Part 2 – Change of director’s interests in contracts

Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be disclosed in this part.

Detail of contract N/A
Nature of interest N/A
Name of registered holder
(if issued securities)
N/A
Date of change N/A
No. and class of securities to which
interest related prior to change
Note: Details are only required for a contract in
relation to which the interest has changed
N/A
Interest acquired N/A
Interest disposed N/A
Value/Consideration
Note: If consideration is non‐cash, provide details
and an estimated valuation
N/A
Interest after change N/A

1 As per Appendix 3Y lodged on 7 May 2021, 2,482 RSUs were granted in lieu of the payment of US$33,131 of Director and Committee fees. RSUs vest and are settled quarterly.

  • See chapter 19 for defined terms.

Appendix 3Y Page 2

01/01/2011

Appendix 3Y Change of Director’s Interest Notice

Part 3 –[+] Closed period

Part 3 –+Closed period
Were the interests in the securities or contracts detailed
above traded during a+closed period where prior written
clearance was required?
No
If so, was prior written clearance provided to allow the trade
to proceed during this period?
N/A
If prior written clearance was provided, on what date was this
provided?
N/A
  • See chapter 19 for defined terms.

01/01/2011 Appendix 3Y Page 3